Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00272012
Status:
COMPLETED
Last Update Posted:
2009-12-07
First Post:
2006-01-02
Brief Title:
OPAL - Insulin Glulisine Diabetes Mellitus
Sponsor:
Sanofi
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
HMR1964A_3507
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sanofi
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Heinz Riederer Medical Director
Old Organization:
Sanofi-aventis Germany